Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,668,003 papers from all fields of science
Search
Sign In
Create Free Account
HIV Long-Term Survivors
Known as:
HIV-1 Long-Term Survivor
, Survivors, HIV Long-Term
, HIV Long Term Survivors
Expand
Persons who have experienced prolonged survival of HIV infection. This includes the full spectrum of untreated, HIV-infected long-term asymptomatics…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
AIDS Long-Term Survivors
HIV Non-Progressors
HIV-1 Nonprogressors
legislation & jurisprudence
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Neruodevelopmental Outcomes in Preschool Children Living With HIV-1 Subtypes A and D in Uganda
H. Ruiseñor-Escudero
,
A. Sikorskii
,
+5 authors
M. Boivin
The Pediatric Infectious Disease Journal
2018
Corpus ID: 13674668
Background: HIV is a neuropathogenic virus that may result in detrimental neurodevelopmental (ND) outcomes early in life. This is…
Expand
Review
2016
Review
2016
Gambaran Subtipe HIV-1 dengan Kadar CD4, Stadium Klinis, dan Infeksi Oportunistik Penderita HIV/AIDS di Kota dan Kabupaten Jayapura, Papua
Mirna Widiyanti
,
Semuel Sandy
2016
Corpus ID: 198272751
Jumlah kasus HIV/AIDS di Indonesia akhir Maret 2013 tercatat 103.759 kasus dan 43.347 kasus AIDS yang tersebar di Indonesia…
Expand
Review
2016
Review
2016
Survivor guilt: The secret burden of cancer survivorship.
M. Shen
,
M. Rigney
,
J. King
Journal of Clinical Oncology
2016
Corpus ID: 23443998
192 Background: The 5-year observed survival rate for a stage IV non-small cell lung cancer patient is one percent. Such a small…
Expand
2009
2009
Prevalence of CCR5-tropic HIV-1 Among Treatment-Experienced Individuals in Spain
S. Moreno
,
B. Clotet
,
+4 authors
R. Sánchez-de la Rosa
HIV Clinical Trials
2009
Corpus ID: 46596036
Abstract Objective: To determine the prevalence of CCR5-tropic HIV-1 among treatment-experienced patients in Spain. Design…
Expand
Review
2006
Review
2006
Modelling thymic HIV-1 Nef effects.
V. Stove
,
B. Verhasselt
Current HIV Research
2006
Corpus ID: 34442889
The nef gene is conserved among primate lentiviruses and is one of the first viral genes that is transcribed following infection…
Expand
2005
2005
AIDS: No association with the genetic systems GC (D-binding protein), ORM (orosomucoid = alpha-1-acid glycoprotein), and A2HS (alpha-2-HS-glycoprotein)
Prof. Dr. H. Cleve
,
Priv. Doz. Dr. S. Weidinger
,
P. D. L. Gürtler
,
P. D. F. Deinhardt
Infection
2005
Corpus ID: 46127056
SummaryIn a sample of 97 HIV-1 seropositive persons which comprised 34 patients with AIDS, 30 patients with persistent…
Expand
2001
2001
HIV-1 Nef: negative effector of Fas?
X. Xu
,
G. Screaton
Nature Immunology
2001
Corpus ID: 34530663
The disappearance of CD4+ T cells during an HIV infection sets the stage for the characteristic immunodeficiency. But how do the…
Expand
2000
2000
Aplicación de los métodos de amplificación molecular para el diagnóstico y seguimiento de la infección por el VIH-1 en niños infectados por transmisión vertical
C. M. Almagro
,
A. González-Cuevas
,
T. J. Morros
,
C. L. Otín
,
Claudia Fortuny Guash
,
M. T. García-Fructuoso
2000
Corpus ID: 72149870
1996
1996
Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users relative to homosexual men.
A. Mocroft
,
C. Sabin
,
A. Phillips
AIDS (London)
1996
Corpus ID: 43830987
1995
1995
Multicentre study for diagnostic evaluation of an assay for simultaneous detection of antibodies to HIV-1, HIV-2 and HIV-1 subtype 0 (HIV-0)
P. Bachmann
,
J. Beyer
,
+8 authors
R. Thorstensson
Infection
1995
Corpus ID: 25657488
SummaryThe aim of the study was to evaluate a new ELISA for detection of HIV-1, HIV-2 and HIV-1 subtype 0 (HIV-0) antibodies. The…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE